Quiet 2007 for Proteomics as M&A Deals, Race for Technology, Gov’t Funding Slow | GenomeWeb
Progress typically happens slowly in proteomics. In 2007, movement was glacial.
 
Agilent Technologies’ expanding profile in the field, a worsening government funding environment, and the continued crawl toward standardized research methods were some of the top trends in the field last year.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.